Joseph E Palys
Examiner (ID: 1283)
Most Active Art Unit | 2413 |
Art Unit(s) | 2413, 2787, 2313, 2899, 2785 |
Total Applications | 453 |
Issued Applications | 351 |
Pending Applications | 23 |
Abandoned Applications | 79 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 3734438
[patent_doc_number] => 05753233
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18'
[patent_app_type] => 1
[patent_app_number] => 8/466285
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2319
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753233.pdf
[firstpage_image] =>[orig_patent_app_number] => 466285
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466285 | Seroreactive epitopes on proteins of human papilloma-virus (HPV) 18 | Jun 5, 1995 | Issued |
Array
(
[id] => 3862425
[patent_doc_number] => 05837264
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Potentiation of immunogenic response'
[patent_app_type] => 1
[patent_app_number] => 8/470278
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 2949
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837264.pdf
[firstpage_image] =>[orig_patent_app_number] => 470278
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470278 | Potentiation of immunogenic response | Jun 5, 1995 | Issued |
Array
(
[id] => 3770442
[patent_doc_number] => 05817318
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Synthetic peptides for an HIV-1 vaccine'
[patent_app_type] => 1
[patent_app_number] => 8/467972
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4396
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817318.pdf
[firstpage_image] =>[orig_patent_app_number] => 467972
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467972 | Synthetic peptides for an HIV-1 vaccine | Jun 5, 1995 | Issued |
Array
(
[id] => 3863052
[patent_doc_number] => 05795955
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-18
[patent_title] => 'Tandem synthetic HIV-1 peptides'
[patent_app_type] => 1
[patent_app_number] => 8/463966
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15877
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/795/05795955.pdf
[firstpage_image] =>[orig_patent_app_number] => 463966
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463966 | Tandem synthetic HIV-1 peptides | Jun 4, 1995 | Issued |
08/462495 | HOG CHOLERA VIRUS VACCINE AND DIAGNOSTIC | Jun 4, 1995 | Abandoned |
Array
(
[id] => 4063332
[patent_doc_number] => 05895650
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-20
[patent_title] => 'Prevention and treatment of retroviral disease'
[patent_app_type] => 1
[patent_app_number] => 8/467334
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 8046
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/895/05895650.pdf
[firstpage_image] =>[orig_patent_app_number] => 467334
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467334 | Prevention and treatment of retroviral disease | Jun 4, 1995 | Issued |
Array
(
[id] => 1533749
[patent_doc_number] => 06410701
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Human neuropeptide receptor'
[patent_app_type] => B1
[patent_app_number] => 08/462509
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18221
[patent_no_of_claims] => 169
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410701.pdf
[firstpage_image] =>[orig_patent_app_number] => 08462509
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462509 | Human neuropeptide receptor | Jun 4, 1995 | Issued |
Array
(
[id] => 4081600
[patent_doc_number] => 06017543
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Prevention and treatment of retroviral disease'
[patent_app_type] => 1
[patent_app_number] => 8/467302
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 8157
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017543.pdf
[firstpage_image] =>[orig_patent_app_number] => 467302
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467302 | Prevention and treatment of retroviral disease | Jun 4, 1995 | Issued |
Array
(
[id] => 3960502
[patent_doc_number] => 05885578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-23
[patent_title] => 'Prevention and treatment of retroviral disease'
[patent_app_type] => 1
[patent_app_number] => 8/469739
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4954
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/885/05885578.pdf
[firstpage_image] =>[orig_patent_app_number] => 469739
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/469739 | Prevention and treatment of retroviral disease | Jun 4, 1995 | Issued |
Array
(
[id] => 3808635
[patent_doc_number] => 05788968
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-04
[patent_title] => 'Methods and compositions for suppressing allograft rejection in mammals'
[patent_app_type] => 1
[patent_app_number] => 8/461661
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6970
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/788/05788968.pdf
[firstpage_image] =>[orig_patent_app_number] => 461661
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461661 | Methods and compositions for suppressing allograft rejection in mammals | Jun 4, 1995 | Issued |
Array
(
[id] => 3921014
[patent_doc_number] => 05876731
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Tandem synthetic HIV-1 Peptides'
[patent_app_type] => 1
[patent_app_number] => 8/462507
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15674
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/876/05876731.pdf
[firstpage_image] =>[orig_patent_app_number] => 462507
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462507 | Tandem synthetic HIV-1 Peptides | Jun 4, 1995 | Issued |
Array
(
[id] => 3771839
[patent_doc_number] => 05773573
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'HIV peptides'
[patent_app_type] => 1
[patent_app_number] => 8/461564
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8065
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773573.pdf
[firstpage_image] =>[orig_patent_app_number] => 461564
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461564 | HIV peptides | Jun 4, 1995 | Issued |
08/465307 | PROTEIN D-AN IGD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE | Jun 4, 1995 | Abandoned |
Array
(
[id] => 3738687
[patent_doc_number] => 05800822
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-01
[patent_title] => 'Tandem synthetic HIV-1 peptides'
[patent_app_type] => 1
[patent_app_number] => 8/465217
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15698
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/800/05800822.pdf
[firstpage_image] =>[orig_patent_app_number] => 465217
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465217 | Tandem synthetic HIV-1 peptides | Jun 4, 1995 | Issued |
Array
(
[id] => 3777131
[patent_doc_number] => 05817754
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-06
[patent_title] => 'Tandem synthetic HIV-1 peptide'
[patent_app_type] => 1
[patent_app_number] => 8/464329
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15653
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/817/05817754.pdf
[firstpage_image] =>[orig_patent_app_number] => 464329
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464329 | Tandem synthetic HIV-1 peptide | Jun 4, 1995 | Issued |
Array
(
[id] => 3697203
[patent_doc_number] => 05674502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-07
[patent_title] => 'Cross-reactive influenza a immunization'
[patent_app_type] => 1
[patent_app_number] => 8/462963
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6932
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/674/05674502.pdf
[firstpage_image] =>[orig_patent_app_number] => 462963
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462963 | Cross-reactive influenza a immunization | Jun 4, 1995 | Issued |
Array
(
[id] => 3764877
[patent_doc_number] => 05733550
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with .beta.-microglobulin'
[patent_app_type] => 1
[patent_app_number] => 8/461213
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 8471
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733550.pdf
[firstpage_image] =>[orig_patent_app_number] => 461213
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461213 | Method for enhancing the association of exogenous peptides with class I MHC molecules on the surface of antigen presenting cells with .beta.-microglobulin | Jun 4, 1995 | Issued |
Array
(
[id] => 3824311
[patent_doc_number] => 05759769
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Tandem synthetic HIV-1 peptides'
[patent_app_type] => 1
[patent_app_number] => 8/460602
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15602
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 500
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759769.pdf
[firstpage_image] =>[orig_patent_app_number] => 460602
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460602 | Tandem synthetic HIV-1 peptides | Jun 1, 1995 | Issued |
Array
(
[id] => 3845005
[patent_doc_number] => 05718904
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Adjuvants for viral vaccines'
[patent_app_type] => 1
[patent_app_number] => 8/459600
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2664
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/718/05718904.pdf
[firstpage_image] =>[orig_patent_app_number] => 459600
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459600 | Adjuvants for viral vaccines | Jun 1, 1995 | Issued |
Array
(
[id] => 3847139
[patent_doc_number] => 05719049
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-17
[patent_title] => 'Process for purifying hepatitis A virus (HAV), virus thus purified and vaccine compositions containing it'
[patent_app_type] => 1
[patent_app_number] => 8/457310
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1615
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/719/05719049.pdf
[firstpage_image] =>[orig_patent_app_number] => 457310
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457310 | Process for purifying hepatitis A virus (HAV), virus thus purified and vaccine compositions containing it | May 31, 1995 | Issued |